WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
688062 Mabwell
- 22.91
- +0.31+1.37%
Market Closed Apr 3 15:00 CST
9.15BMarket Cap-8.77P/E (TTM)
23.88High22.11Low120.02KlotVolume22.48Open22.60Pre Close275.95MTurnover5.88%Turnover RatioLossP/E (Static)399.60MShares36.9952wk High5.84P/B4.68BFloat Cap15.3652wk Low27.12Limit Up204.17MShs Float37.00Historical High18.08Limit Down7.83%Amplitude12.96Historical Low--Dividend TTM22.99Avg Price59.35KlotAsk--Div YieldTTM100Lot Size52.78KlotBid
Mabwell Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 56.28%199.78M | 41.79%141.1M | 28.42%115.53M | 1,572.42%67.56M | 361.03%127.84M | 387.22%99.51M | 713.81%89.96M | -0.70%4.04M | 70.88%27.73M | 90.73%20.42M |
| Operating revenue | 56.28%199.78M | 41.79%141.1M | 28.42%115.53M | 1,572.42%67.56M | 361.03%127.84M | 387.22%99.51M | 713.81%89.96M | -0.70%4.04M | 70.88%27.73M | 90.73%20.42M |
| Total operating cost | 7.14%1.26B | 8.91%844.47M | 12.24%566.93M | 15.37%282.66M | 18.37%1.18B | 7.94%775.39M | 15.15%505.09M | 9.13%245.01M | 21.29%993.42M | 33.01%718.32M |
| Operating cost | 2,013.51%28.95M | 2,532.32%10.64M | 3,320.05%6.17M | 3,930.02%884.47K | 1,839.08%1.37M | 507.44%404.13K | 189.14%180.47K | -62.36%21.95K | -97.71%70.64K | -97.61%66.53K |
| Operating tax surcharges | 59.32%6.05M | 34.62%2.71M | 10.07%1.48M | 4.41%595.14K | 101.54%3.8M | 66.27%2.01M | 72.71%1.35M | 239.71%570.01K | 134.40%1.88M | 120.87%1.21M |
| Operating expense | 34.12%191.67M | 4.46%168.47M | 29.82%113.18M | 50.76%44.15M | 81.99%142.91M | 139.91%161.28M | 120.85%87.18M | 69.67%29.28M | 269.76%78.53M | 379.11%67.22M |
| Administration expense | -5.29%213.53M | 10.19%158.9M | 18.27%111.64M | 7.17%50.98M | 19.23%225.44M | 4.48%144.2M | 2.80%94.39M | -7.10%47.57M | 12.61%189.09M | 18.45%138.03M |
| Financial expense | 209.92%36.73M | 185.42%22.74M | 166.84%12.33M | 141.29%3.9M | 3.89%-33.41M | -13.76%-26.62M | -103.51%-18.44M | -865.15%-9.43M | -1,099.51%-34.76M | -1,134.75%-23.4M |
| -Interest expense (Financial expense) | 332.89%57.78M | 347.66%39.15M | 352.42%25.74M | 336.33%12.28M | 29.64%13.35M | 14.39%8.75M | 14.18%5.69M | 13.64%2.81M | 60.70%10.3M | 57.20%7.65M |
| -Interest Income (Financial expense) | 55.39%-20.92M | 51.78%-17.1M | 44.80%-13.35M | 31.69%-8.41M | -4.11%-46.88M | -13.06%-35.46M | -73.18%-24.18M | -249.35%-12.32M | -1,265.09%-45.03M | -1,042.71%-31.37M |
| Research and development | -6.33%782.87M | -2.65%481.01M | -5.38%322.12M | 2.91%182.15M | 10.17%835.78M | -7.68%494.11M | 7.88%340.43M | 12.89%177M | 21.86%758.61M | 32.51%535.2M |
| Credit Impairment Loss | -34.57%-2.22M | 119.93%2.12M | 83.53%2.06M | -101.49%-19.8K | 2.16%-1.65M | 195.07%965.23K | 190.16%1.12M | 20,336.19%1.33M | -160.40%-1.69M | -137.31%-1.02M |
| Asset Impairment Loss | 41.75%-5.53M | -65.03%-8.42M | -143.61%-7.36M | 3.94%-2.74M | -389.12%-9.49M | -418.52%-5.1M | -74.86%-3.02M | -198.96%-2.85M | 9.52%-1.94M | -2.22%-983.47K |
| Other net revenue | ||||||||||
| Fair value change income | 116.22%493.46K | -42.22%210.23K | -15.86%179.95K | 37.00%83.06K | -381.10%-3.04M | -50.40%363.86K | -34.14%213.86K | 1.74%60.63K | 570.44%1.08M | 740.34%733.66K |
| Invest income | -155.79%-4.22M | -298.72%-2.72M | -388.94%-1.74M | 170.64%249.19K | -331.13%-1.65M | 355.13%1.37M | 372.44%601.23K | -197.84%-352.76K | -82.52%713.6K | -92.14%300.34K |
| -Including: Investment income associates | -172.13%-7.06M | -1,027.67%-5.01M | -849.96%-3.41M | -4.72%-557.85K | -444.55%-2.59M | 10.74%-444.01K | 11.31%-358.72K | -349.80%-532.73K | -170.48%-476.27K | ---497.42K |
| Asset deal income | ---- | ---- | ---- | ---- | -100.18%-602.12 | -79.74%66.41K | 119.63%68.78K | ---- | -84.11%327.85K | --327.85K |
| Other revenue | 147.60%28.01M | 549.18%20.14M | 739.15%14.95M | 500.36%11.32M | 24.92%11.31M | -48.90%3.1M | -60.58%1.78M | 554.28%1.89M | -61.53%9.06M | -14.44%6.07M |
| Operating profit | 0.86%-1.04B | -2.51%-692.03M | -6.99%-443.3M | 14.40%-206.21M | -9.86%-1.05B | 2.51%-675.11M | 2.72%-414.36M | -8.98%-240.9M | -24.00%-958.14M | -34.00%-692.47M |
| Add:Non operating Income | -45.28%32.96K | -45.48%32.84K | -9.30%12.04K | ---- | 57.31%60.24K | 79.81%60.24K | -62.60%13.28K | -100.00%1.44 | 538.16%38.29K | 458.33%33.5K |
| Less:Non operating expense | 45.36%4.02M | 113.23%2.11M | 2.74%1.05M | -100.00%6.98 | 11,075.21%2.77M | 8,199.92%989.2K | 8,621.60%1.02M | --805.16K | 157.69%24.78K | -20.39%11.92K |
| Total profit | 0.74%-1.05B | -2.67%-694.11M | -6.98%-444.34M | 14.68%-206.21M | -10.14%-1.06B | 2.37%-676.04M | 2.48%-415.36M | -9.36%-241.7M | -24.00%-958.13M | -33.99%-692.44M |
| Less:Income tax cost | -125.73%-906.77K | 229.47%1.9M | 229.47%1.9M | ---- | --3.52M | --577.92K | --577.92K | ---- | ---- | ---- |
| Net profit | 1.16%-1.05B | -2.87%-696.02M | -7.29%-446.25M | 14.68%-206.21M | -10.51%-1.06B | 2.29%-676.62M | 2.34%-415.94M | -9.36%-241.7M | -24.00%-958.13M | -33.99%-692.44M |
| Net profit from continuing operation | 1.16%-1.05B | -2.87%-696.02M | -7.29%-446.25M | 14.68%-206.21M | -10.53%-1.06B | 2.29%-676.62M | 2.34%-415.94M | -9.36%-241.7M | -23.98%-957.97M | -33.99%-692.44M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | 99.84%-240.51 | ---240.51 | ---240.51 | ---240.51 | ---152.16K | ---- |
| Less:Minority Profit | 50.82%-2.65M | 42.24%-1.92M | 47.76%-1.26M | 7.89%-552.14K | -86.03%-5.38M | -15,148.21%-3.33M | 8.31%-2.42M | 10.28%-599.43K | 7.12%-2.89M | 98.96%-21.86K |
| Net profit of parent company owners | 0.90%-1.04B | -3.09%-694.09M | -7.61%-444.98M | 14.70%-205.66M | -10.28%-1.05B | 2.76%-673.29M | 2.30%-413.53M | -9.42%-241.11M | -24.12%-955.23M | -34.54%-692.42M |
| Earning per share | ||||||||||
| Basic earning per share | 1.14%-2.61 | -3.57%-1.74 | -7.77%-1.11 | 15.00%-0.51 | -8.20%-2.64 | 2.89%-1.68 | 2.83%-1.03 | -9.09%-0.6 | 5.06%-2.44 | -0.58%-1.73 |
| Diluted earning per share | 1.14%-2.61 | -3.57%-1.74 | -7.77%-1.11 | 15.00%-0.51 | -8.20%-2.64 | 2.89%-1.68 | 2.83%-1.03 | -9.09%-0.6 | 5.06%-2.44 | -0.58%-1.73 |
| Other composite income | -91.40%278.85K | -121.21%-1.02M | -89.82%568.01K | 121.35%123.08K | -22.03%3.24M | -18.44%4.79M | 79.30%5.58M | -130.12%-576.6K | 588.81%4.16M | 2,837.83%5.87M |
| Other composite income of parent company owners | -91.40%278.85K | -121.21%-1.02M | -89.82%568.01K | 121.35%123.08K | -22.03%3.24M | -18.44%4.79M | 79.30%5.58M | -130.12%-576.6K | 588.81%4.16M | 2,837.83%5.87M |
| Total composite income | 0.88%-1.05B | -3.75%-697.03M | -8.61%-445.68M | 14.94%-206.09M | -10.65%-1.06B | 2.15%-671.83M | 2.94%-410.36M | -9.49%-242.28M | -23.32%-953.96M | -32.80%-686.57M |
| Total composite income of parent company owners | 0.62%-1.04B | -3.98%-695.11M | -8.94%-444.41M | 14.96%-205.54M | -10.42%-1.05B | 2.63%-668.5M | 2.91%-407.94M | -9.55%-241.68M | -23.45%-951.07M | -33.34%-686.55M |
| Total composite income of minority owners | 50.82%-2.65M | 42.24%-1.92M | 47.76%-1.26M | 7.89%-552.14K | -86.03%-5.38M | -15,148.21%-3.33M | 8.31%-2.42M | 10.28%-599.43K | 7.12%-2.89M | 98.96%-21.86K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.